Publication:
Adora Risk Identification of Tricyclic Antidepresant

dc.contributor.authorAydin, Macit
dc.contributor.authorYardan, Turker
dc.contributor.authorBaydin, Ahmet
dc.contributor.authorGenc, Selim
dc.contributor.authorIDBAYDIN, AHMET/0000-0003-4987-0878
dc.date.accessioned2020-06-21T13:12:57Z
dc.date.available2020-06-21T13:12:57Z
dc.date.issued2018
dc.departmentOMÜen_US
dc.department-temp[Aydin, Macit -- Genc, Selim] Diskapi Yildirim Beyazit Egitim & Arastirma Hasta, Acil Tip Klin, Ankara, Turkey -- [Yardan, Turker -- Baydin, Ahmet] Ondokuz Mayis Univ, Tip Fak, Acil Tip Anabilim Dali, Samsun, Turkey --en_US
dc.description.abstractObjective: Tricyclic antidepressant (TCA) poisonings can cause serious clinical outcome. The Antidepressant Overdose Risk Assessment (ADORA) criteria are used in the assessment of patients with TCA poisoning. However, the data about the benefits of these criteria in mortality and morbidity prediction in the clinical practice are insufficient. The aim of this study was to determine the relationship of ADORA criteria with clinical outcome. Methods: A total of 133 patients who admitted only with TCA poisoning at a university hospital emergency department. The patients were divided into high risk and low risk groups according to ADORA criteria. Results: The median age was 25 (range 18-55) years. Patients commonly used amitryptiline as TCA agent. According to risk classification; 59.4% of the patients were in high risk group. Most common symptom was mydriasis in study group; somnolence was more frequent in high risk group. The most common finding on electrocardiogram was the right axis deviation and the AVR was the R>S finding. The patients were discharged without any complications. As the number of ADORA positive risk scores increased, the length of hospitalization, QTc height and seizure frequency increased. Conclusion: The ADORA criteria is useful in assessment and clinical follow-up of TCA poisoning.en_US
dc.identifier.doi10.18521/ktd.445529
dc.identifier.endpage221en_US
dc.identifier.issn1309-3878
dc.identifier.issue2en_US
dc.identifier.startpage218en_US
dc.identifier.urihttps://doi.org/10.18521/ktd.445529
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11943
dc.identifier.volume10en_US
dc.identifier.wosWOS:000441304600016
dc.language.isotren_US
dc.publisherDuzce Univen_US
dc.relation.journalKonuralp Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectADORAen_US
dc.subjectThe Antidepressant Overdose Risk Assessmenten_US
dc.subjectPoisoningen_US
dc.subjectTricyclic Antidepressantsen_US
dc.titleAdora Risk Identification of Tricyclic Antidepresanten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files